registry sturdy of severe asthma

registry sturdy of severe asthma - registry sturdy of severe asthma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039409

Enrollment

999

Registered

2020-02-06

Start date

2019-07-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients who are treated with molecular target drugs, or patients who have indication for molecular target therapies. 2. severe asthma patient who need inhaled corticosteroid, long activating beta2 agonist, long activating muscarinic antagonist, leukotriene receptor antagonist, theophylline, oral corticosteroid in order to control asthma

Exclusion criteria

Exclusion criteria: patients who are considered inappropriate by the researchers

Design outcomes

Primary

Measure	Time frame
annual number of exacerbations need systemic corticosteroid	—

Secondary

Measure	Time frame
1. lung function 2. score of questionnaries 3. prescription	—

Countries

Japan

Contacts

Public ContactHisako Matsumoto

Kyoto University Respiratory Medicine

hmatsumo@kuhp.kyoto-u.ac.jp075-751-3830

Outcome results